MarketScreener Editorial Features Fennec Pharmaceuticals Inc Other OTC
Equities
CA31447P1009
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.955 USD | -1.77% | +3.66% | +10.97% |
05-15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
05-14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
MarketScreener Editorial Features
Today on Wall Street: Back to the guessing game | November 29, 2021 at 11:28 am |
- Stock Market
- Equities
- FENC Stock
- Stock
- News Fennec Pharmaceuticals Inc
- MarketScreener Editorial Features